Investing.com - U.S. President Donald Trump's reciprocal tariff policy is likely to face an elongated implementation timeline ...
Investing.com - U.S. President Donald Trump's reciprocal tariff policy is likely to face an elongated implementation timeline, but could still be "big," according to analysts at Wolfe Research.
CVS Health (NYSE:CVS – Free Report) had its target price increased by Wolfe Research from 67.00 to 70.00 in a report ...